![Douglas Giordano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Giordano
Directeur/Membre du Conseil chez
PANACEA ACQUISITION CORP. II
Profil
Douglas Ernest Giordano is President & Director at FoldRx Pharmaceuticals LLC.
Holds director roles at ViiV Healthcare Ltd. since 2012, Cerevel Therapeutics LLC, and Cerevel Therapeutics, Inc. Managing Director & Perceptive Discovery Co-Head at Perceptive Advisors (Private Equity) since 2021.
Independent Director at Panacea Acquisition Corp.
II since 2021 and Independent Non-Executive Director at Kardigan, Inc. since 2024.
Member of the Visitors Board at Duke University School of Medicine and Advisor at New Rhein Healthcare Investors.
Former positions include President, Chief Executive Officer & Director at Anacor Pharmaceuticals LLC; Director at ICU Medical, Inc. from 2017 to 2019; Director at KP Pharmaceuticals LLC; Director at Zoetis, Inc. from 2012 to 2013; President, Treasurer & Director at Medivation LLC (California); Director at Viatris, Inc.; President, Treasurer & Director at Array BioPharma, Inc.; Independent Director at Cerevel Therapeutics Holdings, Inc. from 2018 to 2024; Senior VP-Worldwide Business Development at Pfizer Inc. from 2007 to 2021; President at Serenex, Inc.; Vice President at Icagen, Inc.; and President at Encysive Pharmaceuticals, Inc.Education includes undergraduate studies at Duke University and an MBA from Johnson Graduate School of Management.
Postes actifs de Douglas Giordano
| Sociétés | Poste | Début |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Directeur/Membre du Conseil | 06/04/2021 |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Directeur/Membre du Conseil | - |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Consultant / Advisor | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Private Equity Investor | 01/04/2021 |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cerevel Therapeutics LLC
 Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs to treat disorders of central nervous system | Directeur/Membre du Conseil | - |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | 01/06/2012 |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | President | - |
Anciens postes connus de Douglas Giordano
| Sociétés | Poste | Fin |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/08/2024 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Douglas Giordano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
ICU Medical, Inc.
 ICU Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and sells medical technologies | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Serenex, Inc.
 Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Health Technology |
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zoetis, Inc.
 Zoetis, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs to treat disorders of central nervous system | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
